Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared an article Rami Kobt and colleagues authored on X:
“Nice to see in CLML – great work by our Canadian colleagues Kotb et al! After 2 cycles of isatuximab in Multiple Myeloma, move to 30-min infusions. No montelukast needed, albeit they did keep dex. 30 < 75 min, so less time toxicity for pts and more time for nurses!”
Authored: Rami Kotb et al.
